Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aesthetic Devices Pipeline Market Report Overview

Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. The Aesthetic devices pipeline market research report provides comprehensive information about the aesthetic devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Aesthetic Injectables

·       Hyaluronic Acid Fillers

·       Aesthetic Laser

·       Implants

·       Others

Key Territories ·       United States

·       Europe

·       China

·       South Korea

·       Others

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       NMPA

·       NIFDS

·       TGA

·       HSA

·       ICAC

·       ANVISA

·       BOPA

·       Ninsho

·       MDITAC

·       MDL

·       MDA

·       MDCO

·       INVIMA

·       UKCA

·       Shonin

Leading Companies ·       3D Bio Corp

·       AbbVie Inc

·       Allergan Aesthetics

·       Candela Corp

·       Dexlevo

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Aesthetic Devices Pipeline Market Segments

Some of the key segments in the aesthetic devices pipeline market are aesthetic injectables, implants, hyaluronic acid fillers, aesthetic laser, and others. As of May 2023, aesthetic injectables has the highest share.

Aesthetic Devices Pipeline Market Analysis, by Segments, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the aesthetic devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market Segmentation by Territories

Some key territories with aesthetic devices products in the pipeline are the US, China, South Korea, Israel, and Australia among others. As of May 2023, the US had the highest number of products in the pipeline compared to the other territories.

Aesthetic Devices Pipeline Market Analysis, by Territories, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the aesthetic devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the aesthetic devices pipeline products are 510(k), CE, PMA, NMPA, NIFDS, TGA, HAS, and ICAC among others. As of May 2023, the most deployed regulatory path for the aesthetic devices market was 510(k).

Aesthetic Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Aesthetic Devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market – Competitive Landscape

Some of the leading companies in the Aesthetic Devices pipeline reconstruction market 3D Bio Corp, AbbVie Inc, Allergan Aesthetics, Candela Corp, and Dexlevo among others.

3D Bio Corp: 3D Bio Corp (3D Bio) is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company’s pipeline products includes AuriNovo, AnnuNovo, DiscNovo and NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications. It has lab and factory facilities in Ithaca, New York and engineering workshop in Brooklyn, New York. The company was funded by Kairos Ventures. 3D Bio is headquartered in New York, the US.

Segments Covered in the Report

Aesthetic Devices Pipeline Market Segments Outlook

  • Aesthetic Injectables
  • Hyaluronic Acid Fillers
  • Aesthetic Laser
  • Implants
  • Others

Aesthetic Devices Pipeline Market Territories Outlook

  • United States
  • Europe
  • China
  • Global
  • South Korea
  • Israel
  • Australia
  • Singapore
  • Japan
  • India
  • Brazil
  • Taiwan
  • Mexico
  • Canada
  • Vietnam
  • Malaysia
  • Indonesia
  • Hong Kong
  • Argentina
  • United Kingdom
  • New Zealand
  • Germany
  • Colombia
  • Costa Rica
  • Ecuador
  • Egypt
  • El Salvador
  • Chile
  • Iran
  • Philippines
  • Russia
  • Saudi Arabia
  • Thailand
  • Turkey

Aesthetic Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • NMPA
  • NIFDS
  • TGA
  • HSA
  • ICAC
  • ANVISA
  • BOPA
  • Ninsho
  • MDITAC
  • MDL
  • MDA
  • MDCO
  • INVIMA
  • UKCA
  • Shonin

Scope

  • Extensive coverage of the Aesthetic Devices under development
  • Reviews details of major pipeline reconstruction which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
  • The coverage of pipeline reconstruction based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Aesthetic Devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Bio Corp
AbbVie Inc
Acro Biomedical Co Ltd
Advanced Aesthetic Technologies Inc
Aeon Astron Corporation
Aesthetic Medical Device
Aesthetics BioMedical, Inc.
Aesthetics Point Ltd.
AirXpanders, Inc.
Allergan Aesthetics
Almirall Ltd
Ambicare Health Ltd
AngioDynamics Inc
Apex Medical Device Design LLC
Arula Technolgies
Asymmetric Medical Ltd
B2M Medical Inc
Bausch Health Companies Inc
Becton Dickinson and Co
Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd
Beijing MeiYan KongJian Technology Co Ltd
BellaSeno GmbH
BellaSeno Pty Ltd
Bimini Health Technologies
BioPlus Co Ltd
Biosculpture Technology, Inc.
Biostruxs LLC
Bioxis Pharmaceuticals
BMG Pharma SpA
Bmi Korea Co Ltd
Boston Scientific Corp
Candela Corp
CellPraxis
Celltrix AB
Clearbridge Health Ltd
ClearIt LLC
Collplant Biotechnologies Ltd
Cutera Inc
Cytrellis Biosystems Inc
Delft University of Technology
Dexlevo Inc
Dongkook Pharmaceutical Co Ltd
Emory University
Endomimetics LLC
EP Global Communications Inc (Inactive)
Erchonia Corp
Establishment Labs SA
Eternity Healthcare Inc
EternoGen Aesthetics LLC
Excita Medical
Fillmed Laboratoires
FixNip Ltd
Florida International University
Forticell Bioscience Inc
Fourth State Medicine Ltd
Fumailei Medical Technology Co Ltd
G2GBIO Inc
Galderma SA
GC Aesthetics Plc
Genial Light Co Ltd
Genzyme Corp
Giant Biogene Holding Co Ltd
Hallura Ltd
HansBiomed Co Ltd
Healshape SAS
Histogen Inc
Hugel Inc
Ilooda Co Ltd
ImpLite Ltd.
InMode Ltd
Innova Medical Design
Innovia LLC
inSoma Bio Inc
Intuitive Surgical Inc
Inventage Lab Inc
Jinwoo Bio Co Ltd
Jointechlabs Inc
Juvenis Ltd
Khorionyx SA
Laboratoires Vivacy SAS
Lattice Medical
Lavish
LG Chem Ltd
LifeCell Corp
LifeSprout Inc
LigthSense Israel Ltd
ManaMed Inc
Medality Medical LLC
Medifirst Solutions Inc
Medytox Inc
Mentor Worldwide LLC
Merz North America Inc
Merz Pharma GmbH & Co KgaA
Mesoestetic Pharma Group SL
Moma Therapeutics Inc
N8 Medical LLC
Nanjing Premier Medical Technology Co Ltd
NanoVibronix Inc
National Healthcare Group
Neosthetic, LLC
NivaSonix, LLC
Northwestern University
Nu Skin International Inc.
Oligo Medic Inc
Osteopore International Pte Ltd
Oxtex Ltd (Inactive)
Pantec Biosolutions AG
PB&B SA
Peptron Inc
PetVivo Holdings Inc
Philips Healthcare
PhotoDerma SA
PhotoMedex Inc
PhotoSonix Medical, Inc.
Pinnacle Therapeutics
Plcoskin
PolyNovo Biomaterials Pty Ltd
Pongkece (Shanghai) Intelligent Medical Technology Co Ltd
Prayasta 3D Inventions Pvt Ltd
Precise Bio Ltd
PS Advanced Engineering
Q-Med AB
Ra Medical Systems Inc
Recros Medica Inc
RepliCel Life Sciences Inc
Samyang Biopharmaceuticals Corp
SANUWAVE Health Inc
Sebana Medical Ltd
Shanghai Haohai Biological Technology Co Ltd
Shanghai Liuqiang Medical Technology Co Ltd
Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd
Shin Poong Pharm Co Ltd
Sienna Biopharmaceuticals Inc (Inactive)
Sientra Inc
Sihuan Pharmaceutical Holdings Group Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Slender Medical Ltd.
SMSbiotech Inc
Sofregen Medical Inc
SofWave Medical Ltd
Soliton Inc
Solta Medical Inc
Southern Illinois University Carbondale
STRATA Skin Sciences Inc
SunMax Biotechnology Co Ltd
Symatese Aesthetics
TEI Biosciences Inc
Tempo Therapeutics Inc
Tensive SRL
Teoxane SA
Tetratherix Pty Ltd
TeVido BioDevices LLC
Tissue Regeneration Technologies LLC
Tissueform Inc
University of California Irvine
University of California Santa Barbara
University of Missouri
University of Pittsburgh
University of Texas at Austin
Uronext LLC
USkin Ltd
Vanderbilt University
Venus Concept Inc
VisageX Medical Ltd
Wuhan Tianshiwei Holdings Co Ltd
Xi'an Lanji Medical Electronic Technology Co Ltd
Zeltiq Aesthetics Inc
Zift Medical LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 13

|1.2 List of Figures 30

2 Introduction 31

2.1 Aesthetic Devices Overview 31

3 Products under Development 33

3.1 Aesthetic Devices – Pipeline Products by Stage of Development 33

3.2 Aesthetic Devices – Pipeline Products by Segment 34

3.3 Aesthetic Devices – Pipeline Products by Territory 36

3.4 Aesthetic Devices – Pipeline Products by Regulatory Path 38

3.5 Aesthetic Devices – Pipeline Products by Estimated Approval Date 39

3.6 Aesthetic Devices – Ongoing Clinical Trials 40

4 Aesthetic Devices – Pipeline Products under Development by Companies 41

4.1 Aesthetic Devices Companies – Pipeline Products by Stage of Development 41

4.2 Aesthetic Devices – Pipeline Products by Stage of Development 48

5 Aesthetic Devices Companies and Product Overview 56

5.1 3D Bio Corp Company Overview 56

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 56

5.2 AbbVie Inc Company Overview 57

5.2.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.3 Acro Biomedical Co Ltd Company Overview 58

5.3.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.4 Advanced Aesthetic Technologies Inc Company Overview 59

5.4.1 Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.5 Aeon Astron Corporation Company Overview 64

5.5.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 64

5.6 Aesthetic Medical Device Company Overview 66

5.6.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 66

5.7 Aesthetics BioMedical, Inc. Company Overview 69

5.7.1 Aesthetics BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

5.8 Aesthetics Point Ltd. Company Overview 70

5.8.1 Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

5.9 AirXpanders, Inc. Company Overview 71

5.9.1 AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.10 Allergan Aesthetics Company Overview 72

5.10.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 72

5.11 Almirall Ltd Company Overview 87

5.11.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

5.12 Ambicare Health Ltd Company Overview 88

5.12.1 Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

5.13 AngioDynamics Inc Company Overview 89

5.13.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.14 Apex Medical Device Design LLC Company Overview 90

5.14.1 Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.15 Arula Technolgies Company Overview 91

5.15.1 Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 91

5.16 Asymmetric Medical Ltd Company Overview 92

5.16.1 Asymmetric Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.17 B2M Medical Inc Company Overview 93

5.17.1 B2M Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.18 Bausch Health Companies Inc Company Overview 94

5.18.1 Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.19 Becton Dickinson and Co Company Overview 97

5.19.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 97

5.20 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Company Overview 98

5.20.1 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.21 Beijing MeiYan KongJian Technology Co Ltd Company Overview 99

5.21.1 Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

5.22 BellaSeno GmbH Company Overview 102

5.22.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 102

5.23 BellaSeno Pty Ltd Company Overview 105

5.23.1 BellaSeno Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.24 Bimini Health Technologies Company Overview 108

5.24.1 Bimini Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 108

5.25 BioPlus Co Ltd Company Overview 111

5.25.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

5.26 Biosculpture Technology, Inc. Company Overview 114

5.26.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

5.27 Biostruxs LLC Company Overview 116

5.27.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 116

5.28 Bioxis Pharmaceuticals Company Overview 117

5.28.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 117

5.29 BMG Pharma SpA Company Overview 120

5.29.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 120

5.30 Bmi Korea Co Ltd Company Overview 122

5.30.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.31 Boston Scientific Corp Company Overview 123

5.31.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 123

5.32 Candela Corp Company Overview 125

5.32.1 Candela Corp Pipeline Products & Ongoing Clinical Trials Overview 125

5.33 CellPraxis Company Overview 126

5.33.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 126

5.34 Celltrix AB Company Overview 127

5.34.1 Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 127

5.35 Clearbridge Health Ltd Company Overview 128

5.35.1 Clearbridge Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

5.36 ClearIt LLC Company Overview 129

5.36.1 ClearIt LLC Pipeline Products & Ongoing Clinical Trials Overview 129

5.37 Collplant Biotechnologies Ltd Company Overview 130

5.37.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.38 Cutera Inc Company Overview 134

5.38.1 Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.39 Cytrellis Biosystems Inc Company Overview 137

5.39.1 Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.40 Delft University of Technology Company Overview 140

5.40.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 140

5.41 Dexlevo Inc Company Overview 141

5.41.1 Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.42 Dongkook Pharmaceutical Co Ltd Company Overview 142

5.42.1 Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 142

5.43 Emory University Company Overview 145

5.43.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 145

5.44 Endomimetics LLC Company Overview 146

5.44.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 146

5.45 EP Global Communications Inc (Inactive) Company Overview 147

5.45.1 EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

5.46 Erchonia Corp Company Overview 148

5.46.1 Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 148

5.47 Establishment Labs SA Company Overview 151

5.47.1 Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 151

5.48 Eternity Healthcare Inc Company Overview 166

5.48.1 Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 166

5.49 EternoGen Aesthetics LLC Company Overview 167

5.49.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 167

5.50 Excita Medical Company Overview 168

5.50.1 Excita Medical Pipeline Products & Ongoing Clinical Trials Overview 168

5.51 Fillmed Laboratoires Company Overview 169

5.51.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 169

5.52 FixNip Ltd Company Overview 171

5.52.1 FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

5.53 Florida International University Company Overview 172

5.53.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 172

5.54 Forticell Bioscience Inc Company Overview 173

5.54.1 Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.55 Fourth State Medicine Ltd Company Overview 174

5.55.1 Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.56 Fumailei Medical Technology Co Ltd Company Overview 175

5.56.1 Fumailei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

5.57 G2GBIO Inc Company Overview 177

5.57.1 G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.58 Galderma SA Company Overview 178

5.58.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 178

5.59 GC Aesthetics Plc Company Overview 179

5.59.1 GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 179

5.60 Genial Light Co Ltd Company Overview 180

5.60.1 Genial Light Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 180

5.61 Genzyme Corp Company Overview 181

5.61.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 181

5.62 Giant Biogene Holding Co Ltd Company Overview 182

5.62.1 Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.63 Hallura Ltd Company Overview 185

5.63.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

5.64 HansBiomed Co Ltd Company Overview 187

5.64.1 HansBiomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

5.65 Healshape SAS Company Overview 190

5.65.1 Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 190

5.66 Histogen Inc Company Overview 191

5.66.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.67 Hugel Inc Company Overview 192

5.67.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 192

5.68 Ilooda Co Ltd Company Overview 196

5.68.1 Ilooda Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 196

5.69 ImpLite Ltd. Company Overview 197

5.69.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 197

5.70 InMode Ltd Company Overview 198

5.70.1 InMode Ltd Pipeline Products & Ongoing Clinical Trials Overview 198

5.71 Innova Medical Design Company Overview 202

5.71.1 Innova Medical Design Pipeline Products & Ongoing Clinical Trials Overview 202

5.72 Innovia LLC Company Overview 203

5.72.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 203

5.73 inSoma Bio Inc Company Overview 205

5.73.1 inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 205

5.74 Intuitive Surgical Inc Company Overview 206

5.74.1 Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.75 Inventage Lab Inc Company Overview 207

5.75.1 Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 207

5.76 Jinwoo Bio Co Ltd Company Overview 210

5.76.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

5.77 Jointechlabs Inc Company Overview 213

5.77.1 Jointechlabs Inc Pipeline Products & Ongoing Clinical Trials Overview 213

5.78 Juvenis Ltd Company Overview 214

5.78.1 Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.79 Khorionyx SA Company Overview 215

5.79.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 215

5.80 Laboratoires Vivacy SAS Company Overview 216

5.80.1 Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 216

5.81 Lattice Medical Company Overview 219

5.81.1 Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 219

5.82 Lavish Company Overview 222

5.82.1 Lavish Pipeline Products & Ongoing Clinical Trials Overview 222

5.83 LG Chem Ltd Company Overview 225

5.83.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

5.84 LifeCell Corp Company Overview 234

5.84.1 LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 234

5.85 LifeSprout Inc Company Overview 236

5.85.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 236

5.86 LigthSense Israel Ltd Company Overview 240

5.86.1 LigthSense Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 240

5.87 ManaMed Inc Company Overview 243

5.87.1 ManaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 243

5.88 Medality Medical LLC Company Overview 244

5.88.1 Medality Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 244

5.89 Medifirst Solutions Inc Company Overview 247

5.89.1 Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 247

5.90 Medytox Inc Company Overview 248

5.90.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 248

5.91 Mentor Worldwide LLC Company Overview 252

5.91.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 252

5.92 Merz North America Inc Company Overview 253

5.92.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 253

5.93 Merz Pharma GmbH & Co KgaA Company Overview 256

5.93.1 Merz Pharma GmbH & Co KgaA Pipeline Products & Ongoing Clinical Trials Overview 256

5.94 Mesoestetic Pharma Group SL Company Overview 258

5.94.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 258

5.95 Moma Therapeutics Inc Company Overview 262

5.95.1 Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 262

5.96 N8 Medical LLC Company Overview 263

5.96.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 263

5.97 Nanjing Premier Medical Technology Co Ltd Company Overview 264

5.97.1 Nanjing Premier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 264

5.98 NanoVibronix Inc Company Overview 266

5.98.1 NanoVibronix Inc Pipeline Products & Ongoing Clinical Trials Overview 266

5.99 National Healthcare Group Company Overview 267

5.99.1 National Healthcare Group Pipeline Products & Ongoing Clinical Trials Overview 267

5.100 Neosthetic, LLC Company Overview 268

5.100.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 268

5.101 NivaSonix, LLC Company Overview 269

5.101.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 269

5.102 Northwestern University Company Overview 270

5.102.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 270

5.103 Nu Skin International Inc. Company Overview 271

5.103.1 Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 271

5.104 Oligo Medic Inc Company Overview 273

5.104.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 273

5.105 Osteopore International Pte Ltd Company Overview 274

5.105.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 274

5.106 Oxtex Ltd (Inactive) Company Overview 277

5.106.1 Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 277

5.107 Pantec Biosolutions AG Company Overview 279

5.107.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 279

5.108 PB&B SA Company Overview 280

5.108.1 PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 280

5.109 Peptron Inc Company Overview 281

5.109.1 Peptron Inc Pipeline Products & Ongoing Clinical Trials Overview 281

5.110 PetVivo Holdings Inc Company Overview 282

5.110.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 282

5.111 Philips Healthcare Company Overview 284

5.111.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 284

5.112 PhotoDerma SA Company Overview 285

5.112.1 PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 285

5.113 PhotoMedex Inc Company Overview 287

5.113.1 PhotoMedex Inc Pipeline Products & Ongoing Clinical Trials Overview 287

5.114 PhotoSonix Medical, Inc. Company Overview 289

5.114.1 PhotoSonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 289

5.115 Pinnacle Therapeutics Company Overview 290

5.115.1 Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 290

5.116 Plcoskin Company Overview 291

5.116.1 Plcoskin Pipeline Products & Ongoing Clinical Trials Overview 291

5.117 PolyNovo Biomaterials Pty Ltd Company Overview 292

5.117.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 292

5.118 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Company Overview 295

5.118.1 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 295

5.119 Prayasta 3D Inventions Pvt Ltd Company Overview 296

5.119.1 Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 296

5.120 Precise Bio Ltd Company Overview 297

5.120.1 Precise Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 297

5.121 PS Advanced Engineering Company Overview 298

5.121.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 298

5.122 Q-Med AB Company Overview 300

5.122.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 300

5.123 Ra Medical Systems Inc Company Overview 305

5.123.1 Ra Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 305

5.124 Recros Medica Inc Company Overview 306

5.124.1 Recros Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 306

5.125 RepliCel Life Sciences Inc Company Overview 311

5.125.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 311

5.126 Samyang Biopharmaceuticals Corp Company Overview 312

5.126.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 312

5.127 SANUWAVE Health Inc Company Overview 315

5.127.1 SANUWAVE Health Inc Pipeline Products & Ongoing Clinical Trials Overview 315

5.128 Sebana Medical Ltd Company Overview 318

5.128.1 Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 318

5.129 Shanghai Haohai Biological Technology Co Ltd Company Overview 319

5.129.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 319

5.130 Shanghai Liuqiang Medical Technology Co Ltd Company Overview 321

5.130.1 Shanghai Liuqiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 321

5.131 Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd Company Overview 322

5.131.1 Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 322

5.132 Shin Poong Pharm Co Ltd Company Overview 323

5.132.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 323

5.133 Sienna Biopharmaceuticals Inc (Inactive) Company Overview 324

5.133.1 Sienna Biopharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 324

5.134 Sientra Inc Company Overview 327

5.134.1 Sientra Inc Pipeline Products & Ongoing Clinical Trials Overview 327

5.135 Sihuan Pharmaceutical Holdings Group Ltd Company Overview 329

5.135.1 Sihuan Pharmaceutical Holdings Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 329

5.136 Silk Medical Aesthetics Inc Company Overview 330

5.136.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 330

5.137 Sinclair Pharma Ltd Company Overview 334

5.137.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 334

5.138 Slender Medical Ltd. Company Overview 338

5.138.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 338

5.139 SMSbiotech Inc Company Overview 340

5.139.1 SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview 340

5.140 Sofregen Medical Inc Company Overview 341

5.140.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 341

5.141 SofWave Medical Ltd Company Overview 344

5.141.1 SofWave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 344

5.142 Soliton Inc Company Overview 349

5.142.1 Soliton Inc Pipeline Products & Ongoing Clinical Trials Overview 349

5.143 Solta Medical Inc Company Overview 356

5.143.1 Solta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 356

5.144 Southern Illinois University Carbondale Company Overview 358

5.144.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 358

5.145 STRATA Skin Sciences Inc Company Overview 359

5.145.1 STRATA Skin Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 359

5.146 SunMax Biotechnology Co Ltd Company Overview 362

5.146.1 SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 362

5.147 Symatese Aesthetics Company Overview 367

5.147.1 Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 367

5.148 TEI Biosciences Inc Company Overview 370

5.148.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 370

5.149 Tempo Therapeutics Inc Company Overview 371

5.149.1 Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 371

5.150 Tensive SRL Company Overview 372

5.150.1 Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 372

5.151 Teoxane SA Company Overview 375

5.151.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 375

5.152 Tetratherix Pty Ltd Company Overview 379

5.152.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 379

5.153 TeVido BioDevices LLC Company Overview 380

5.153.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 380

5.154 Tissue Regeneration Technologies LLC Company Overview 381

5.154.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 381

5.155 Tissueform Inc Company Overview 382

5.155.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 382

5.156 University of California Irvine Company Overview 383

5.156.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 383

5.157 University of California Santa Barbara Company Overview 384

5.157.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 384

5.158 University of Missouri Company Overview 385

5.158.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 385

5.159 University of Pittsburgh Company Overview 386

5.159.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 386

5.160 University of Texas at Austin Company Overview 387

5.160.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 387

5.161 Uronext LLC Company Overview 390

5.161.1 Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview 390

5.162 USkin Ltd Company Overview 391

5.162.1 USkin Ltd Pipeline Products & Ongoing Clinical Trials Overview 391

5.163 Vanderbilt University Company Overview 392

5.163.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 392

5.164 Venus Concept Inc Company Overview 393

5.164.1 Venus Concept Inc Pipeline Products & Ongoing Clinical Trials Overview 393

5.165 VisageX Medical Ltd Company Overview 397

5.165.1 VisageX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 397

5.166 Wuhan Tianshiwei Holdings Co Ltd Company Overview 398

5.166.1 Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 398

5.167 Xi’an Lanji Medical Electronic Technology Co Ltd Company Overview 399

5.167.1 Xi’an Lanji Medical Electronic Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 399

5.168 Zeltiq Aesthetics Inc Company Overview 400

5.168.1 Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 400

5.169 Zift Medical LLC Company Overview 407

5.169.1 Zift Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 407

6 Aesthetic Devices- Recent Developments 410

7 Appendix

Table

Aesthetic Devices – Pipeline Products by Stage of Development 33

Aesthetic Devices – Pipeline Products by Segment 34

Aesthetic Devices – Pipeline Products by Territory 36

Aesthetic Devices – Pipeline Products by Regulatory Path 38

Aesthetic Devices – Pipeline Products by Estimated Approval Date 39

Aesthetic Devices – Ongoing Clinical Trials 40

Aesthetic Devices Companies – Pipeline Products by Stage of Development 41

Aesthetic Devices – Pipeline Products by Stage of Development 48

3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 56

3D Printed Breast Implant – Lupectomy Reconstruction – Product Status 56

3D Printed Breast Implant – Lupectomy Reconstruction – Product Description 56

AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Hyaluronic Acid Filler – Skin – Product Status 57

Hyaluronic Acid Filler – Skin – Product Description 57

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

ACROFILL – Product Status 58

ACROFILL – Product Description 58

Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Algeness DF – Product Status 59

Algeness DF – Product Description 59

Algeness HD – Product Status 60

Algeness HD – Product Description 60

Algeness LD – Product Status 60

Algeness LD – Product Description 61

Algeness VL – Product Status 61

Algeness VL – Product Description 61

Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 62

Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 63

Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 63

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 64

BioDermal Filler – Product Status 64

BioDermal Filler – Product Description 64

Prosthetic Chin – Product Status 65

Prosthetic Chin – Product Description 65

Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 66

Alluris – Product Status 66

Alluris – Product Description 66

Skinlumina – Product Status 67

Skinlumina – Product Description 67

SkinTechMD – Product Status 67

SkinTechMD – Product Description 68

Aesthetics BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

Vivace Ultra – Product Status 69

Vivace Ultra – Product Description 69

Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

Juvence Implant – Product Status 70

Juvence Implant – Product Description 70

AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

Smooth Shell AeroForm Tissue Expander System – Product Status 71

Smooth Shell AeroForm Tissue Expander System – Product Description 71

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 72

AAM SubQ Body Filler – Product Status 72

AAM SubQ Body Filler – Product Description 73

ADM Subdermal Body Filler – Product Status 73

ADM Subdermal Body Filler – Product Description 73

Elastagen – Acne Scars – Product Status 73

Elastagen – Acne Scars – Product Description 74

Elastagen – Skin Quality – Product Status 74

Elastagen – Skin Quality – Product Description 74

Eplica Silk – Product Status 74

Eplica Silk – Product Description 75

HA Threads – Product Status 75

HA Threads – Product Description 75

Inspira TF2 – Breast Augmentation – Product Status 75

Inspira TF2 – Breast Augmentation – Product Description 76

Juvederm – Decolletage – Product Status 76

Juvederm – Decolletage – Product Description 76

Juvederm – Hands – Product Status 76

Juvederm – Hands – Product Description 77

Juvederm – Neck Lines – Product Status 77

Juvederm – Neck Lines – Product Description 77

Juvederm RejuveCross – Deep Wrinkles – Product Status 77

Juvederm RejuveCross – Deep Wrinkles – Product Description 78

Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 78

Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 78

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 78

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 79

Juvederm Voluma – Nose – Product Status 79

Juvederm Voluma – Nose – Product Description 79

Juvederm Voluma – Temple – Product Status 79

Juvederm Voluma – Temple – Product Description 80

Juvederm Voluma Global – Malar Augmentation – Product Status 80

Juvederm Voluma Global – Malar Augmentation – Product Description 80

Larger Inspira TE – Product Status 80

Larger Inspira TE – Product Description 81

Phoenix – Breast Augmentation – Product Status 81

Phoenix – Breast Augmentation – Product Description 81

rhCollagen Dermal Filler – Product Status 81

rhCollagen Dermal Filler – Product Description 82

SeriGel – Product Status 82

SeriGel – Product Description 82

Skin Quattro Device – Product Status 83

Skin Quattro Device – Product Description 83

Allergan Aesthetics – Ongoing Clinical Trials Overview 84

Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 85

Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 85

Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 86

Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

Hyaluronic Acid Facial Filler – Product Status 87

Hyaluronic Acid Facial Filler – Product Description 87

Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

Ambulight Rejuvenate – Product Status 88

Ambulight Rejuvenate – Product Description 88

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Next Generation Laser – Product Status 89

Next Generation Laser – Product Description 89

Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 90

DefyGravity – Product Status 90

DefyGravity – Product Description 90

Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 91

Breast Prosthesis – Product Status 91

Breast Prosthesis – Product Description 91

Asymmetric Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

Asymmetric Laser Tool – Product Status 92

Asymmetric Laser Tool – Product Description 92

B2M Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Mesenteric Fat Cryolipolysis Device – Product Status 93

Mesenteric Fat Cryolipolysis Device – Product Description 93

Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 94

SOF – 010: Skin Resurfacing – Product Status 94

SOF – 010: Skin Resurfacing – Product Description 94

SOM – 010: Vascular Lesions – Product Status 95

SOM – 010: Vascular Lesions – Product Description 95

SOT – 010: Fine Lines & wrinkles – Product Status 95

SOT – 010: Fine Lines & wrinkles – Product Description 95

SOT – 011: Fine Lines & Wrinkles – Product Status 96

SOT – 011: Fine Lines & Wrinkles – Product Description 96

XUA – 001: Hair Removal – Product Status 96

XUA – 001: Hair Removal – Product Description 96

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 97

Endo Laser – Product Status 97

Endo Laser – Product Description 97

Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

ECM Composite Collagen – Product Status 98

ECM Composite Collagen – Product Description 98

Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

Complex Collagen Filler (Type III) – Product Status 99

Complex Collagen Filler (Type III) – Product Description 99

First Generation PLLA Filler (Type III) – Product Status 100

First Generation PLLA Filler (Type III) – Product Description 100

Second Generation PCL Filler (Type III) – Product Status 100

Second Generation PCL Filler (Type III) – Product Description 101

BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 102

Senella Scaffold – Product Status 102

Senella Scaffold – Product Description 102

BellaSeno GmbH – Ongoing Clinical Trials Overview 103

Senella Scaffold – Clinical Trial Evaluating Feasibility and Safety of Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation with Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery 104

BellaSeno Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Status 105

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Description 105

BellaSeno Pty Ltd – Ongoing Clinical Trials Overview 106

3D Printed Pectus Scaffold Implant – Pectus Excavatum – A Clinical Trial Evaluating Medical-Grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage 107

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Pectus Scaffold Implantation With Autologous Fat Grafting for Pectus Excavatum Camouflage (IT) 107

Bimini Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 108

Dermapose Fat Removal and Transfer System – Product Status 108

Dermapose Fat Removal and Transfer System – Product Description 108

Kerastem – Product Status 109

Kerastem – Product Description 109

Puregraft Boost Adipose Micronizer – Product Status 109

Puregraft Boost Adipose Micronizer – Product Description 110

Puregraft Microfat – Product Status 110

Puregraft Microfat – Product Description 110

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

Biological Breast – Product Status 111

Biological Breast – Product Description 111

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 112

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 112

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 112

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 113

Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

Airbrush Liposculptor IIE – Product Status 114

Airbrush Liposculptor IIE – Product Description 114

Airbrush Liposculptor IIIE – Product Status 115

Airbrush Liposculptor IIIE – Product Description 115

Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 116

BioBreast Scaffold – Product Status 116

BioBreast Scaffold – Product Description 116

Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 117

Cytosmile – Product Status 117

Cytosmile – Product Description 117

MTI-12 – Product Status 118

MTI-12 – Product Description 118

MTI-12 – Surgical Repair – Product Status 118

MTI-12 – Surgical Repair – Product Description 119

BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 120

SGA300 – Product Status 120

SGA300 – Product Description 120

SGA302 – Product Status 121

SGA302 – Product Description 121

SGA320 – Product Status 121

SGA320 – Product Description 121

Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

BMI4002 – Product Status 122

BMI4002 – Product Description 122

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 123

Next Gen Greenlight Fiber System – Product Status 123

Next Gen Greenlight Fiber System – Product Description 123

Starfire Laser – Product Status 124

Starfire Laser – Product Description 124

Candela Corp Pipeline Products & Ongoing Clinical Trials Overview 125

Pneumatic Skin Fattening For Telangectasia – Product Status 125

Pneumatic Skin Fattening For Telangectasia – Product Description 125

CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 126

Lipage – Product Status 126

Lipage – Product Description 126

Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 127

Credurance – Product Status 127

Credurance – Product Description 127

Clearbridge Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

Nanofibrous Scaffold – Product Status 128

Nanofibrous Scaffold – Product Description 128

ClearIt LLC Pipeline Products & Ongoing Clinical Trials Overview 129

ERASER System – Product Status 129

ERASER System – Product Description 129

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

3D Bioprinted Regenerative Breast Implant – Product Status 130

3D Bioprinted Regenerative Breast Implant – Product Description 131

3D Bioprinted Regenerative Soft Tissue Matrix – Product Status 131

3D Bioprinted Regenerative Soft Tissue Matrix – Product Description 131

Injectable Breast Implant – Product Status 132

Injectable Breast Implant – Product Description 132

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Status 132

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Description 133

rhCollagen Based Soft Tissue Filler – Product Status 133

rhCollagen Based Soft Tissue Filler – Product Description 133

Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 134

enlighten Multi-Wavelength – Tattoo Removal – Product Status 134

enlighten Multi-Wavelength – Tattoo Removal – Product Description 134

Cutera Inc – Ongoing Clinical Trials Overview 135

enlighten Multi-Wavelength – Tattoo Removal – A Multi-center Pilot Study of a Novel Multi-wavelength Laser for Tattoo Removal 136

Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 137

Micro-Excision Device – Product Status 137

Micro-Excision Device – Product Description 137

Cytrellis Biosystems Inc – Ongoing Clinical Trials Overview 138

Micro-Excision Device – A Prospective, Multi-center, Pilot Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-coring Device for the Treatment of Scars 139

Micro-Excision Device – A Prospective, Multi-center, Pivotal Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles 139

Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 140

DPS Controlled Laser Coagulation Needle – Product Status 140

DPS Controlled Laser Coagulation Needle – Product Description 140

Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 141

Gouri – Product Status 141

Gouri – Product Description 141

Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 142

DKB-119 – Product Status 142

DKB-119 – Product Description 142

DKB-133 – Product Status 143

DKB-133 – Product Description 143

DKM-410 – Product Status 143

DKM-410 – Product Description 144

DKM-423 – Product Status 144

DKM-423 – Product Description 144

Emory University Pipeline Products & Ongoing Clinical Trials Overview 145

Nasolabial Fold Implant – Product Status 145

Nasolabial Fold Implant – Product Description 145

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 146

Silicone Implant – Product Status 146

Silicone Implant – Product Description 146

EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

MEMS Nerve Ablation Device – Facial Glabellar Frowning – Product Status 147

MEMS Nerve Ablation Device – Facial Glabellar Frowning – Product Description 147

Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 148

Erchonia HLS Laser – Product Status 148

Erchonia HLS Laser – Product Description 148

Erchonia ML Scanner – Female Hair Restoration – Product Status 149

Erchonia ML Scanner – Female Hair Restoration – Product Description 149

Erchonia ML Scanner – Venous Stasis Ulcers – Product Status 149

Erchonia ML Scanner – Venous Stasis Ulcers – Product Description 150

Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 151

Mia Femtech – Product Status 152

Mia Femtech – Product Description 152

Motiva Ergonomix – Product Status 152

Motiva Ergonomix – Product Description 153

Motiva Ergonomix2 – Product Status 153

Motiva Ergonomix2 – Product Description 153

Motiva Ergonomix2 Diamond Breast Implant – Product Status 154

Motiva Ergonomix2 Diamond Breast Implant – Product Description 154

Motiva Flora Tissue Expander – Product Status 154

Motiva Flora Tissue Expander – Product Description 155

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Status 155

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Description 155

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Status 156

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Description 156

Motiva MIA – Product Status 156

Motiva MIA – Product Description 157

Motiva Round – Product Status 157

Motiva Round – Product Description 158

SmoothSilk Anatomical Tissue Expander – Product Status 158

SmoothSilk Anatomical Tissue Expander – Product Description 158

Establishment Labs SA – Ongoing Clinical Trials Overview 159

Motiva Round – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 160

Motiva Round – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 160

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 161

Motiva Ergonomix – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 162

Motiva Ergonomix – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 162

SmoothSilk Anatomical Tissue Expander – Immunological Analysis of Capsular Tissue Formed Around Expanders With Varying Surface Topography in Women Undergoing Bilateral Nipple or Skin Sparing Mastectomy 163

SmoothSilk Anatomical Tissue Expander – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 163

Motiva Flora Tissue Expander – Post-Marketing Clinical Follow-Up Study to Confirm the Safety and Effectiveness/Performance of Motiva Flora Tissue Expander in Staged Breast Reconstruction Surgery 164

Motiva Flora Tissue Expander – Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction 164

Motiva MIA – A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants 165

Motiva MIA – Multicenter Study to Evaluate Motiva Mia System for Minimally Invasive Augmentation in Thailand 165

Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 166

Hand-held Laser Hair Removal Device – Product Status 166

Hand-held Laser Hair Removal Device – Product Description 166

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 167

Cellifique – Product Status 167

Cellifique – Product Description 167

Excita Medical Pipeline Products & Ongoing Clinical Trials Overview 168

Electrical Muscle Stimulation Device – Product Status 168

Electrical Muscle Stimulation Device – Product Description 168

Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 169

NCTF 135 – Product Status 169

NCTF 135 – Product Description 169

NCTF 135 HA – Product Status 170

NCTF 135 HA – Product Description 170

FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

FixNip NRI – Product Status 171

FixNip NRI – Product Description 171

Florida International University Pipeline Products & Ongoing Clinical Trials Overview 172

Cosmetic Skin Treatment Device – Product Status 172

Cosmetic Skin Treatment Device – Product Description 172

Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 173

Haptized Collagen Tissue Augmentation Device – Product Status 173

Haptized Collagen Tissue Augmentation Device – Product Description 173

Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

Nebulaskin – Product Status 174

Nebulaskin – Product Description 174

Fumailei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

ForePico – Product Status 175

ForePico – Product Description 175

Long-Pulse Width Laser Therapy Instrument – Product Status 176

Long-Pulse Width Laser Therapy Instrument – Product Description 176

G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 177

GB-3001 – Product Status 177

GB-3001 – Product Description 177

Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 178

Biostimulator Filler – Product Status 178

Biostimulator Filler – Product Description 178

GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 179

PERLE – Product Status 179

PERLE – Product Description 179

Genial Light Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 180

Genial Bone Laser – Product Status 180

Genial Bone Laser – Product Description 180

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 181

Prevelle Lift – Product Status 181

Prevelle Lift – Product Description 181

Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

Cross-Linking Recombinant Collagen Skin Rejuvenation Gel – Product Status 182

Cross-Linking Recombinant Collagen Skin Rejuvenation Gel – Product Description 182

Recombinant Collagen Skin Rejuvenation Gel – Product Status 183

Recombinant Collagen Skin Rejuvenation Gel – Product Description 183

Recombinant Collagen Sterile Dressing – Product Status 183

Recombinant Collagen Sterile Dressing – Product Description 184

Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

BiOLinkMatrix Gel – Product Status 185

BiOLinkMatrix Gel – Product Description 185

Hyaluronic Acid Dermal Filler – Product Status 186

Hyaluronic Acid Dermal Filler – Product Description 186

HansBiomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

Bellagel SmoothFine – Product Status 187

Bellagel SmoothFine – Product Description 187

HansBiomed Co Ltd – Ongoing Clinical Trials Overview 188

Bellagel SmoothFine – Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-filled Breast Implant (CoSBI) in Women Aged 22 and Over with Breast Reconstruction or Augmentation Mammoplasty 189

Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 190

3D Printed Breast Implant – Product Status 190

3D Printed Breast Implant – Product Description 190

Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 191

HST002 – Product Status 191

HST002 – Product Description 191

Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 192

The Chaeum Pure No.1 – Product Status 192

The Chaeum Pure No.1 – Product Description 193

The Chaeum Pure No.2 – Product Status 193

The Chaeum Pure No.2 – Product Description 193

The Chaeum Pure No.3 – Product Status 194

The Chaeum Pure No.3 – Product Description 194

The Chaeum Pure No.4 – Product Status 194

The Chaeum Pure No.4 – Product Description 195

The Chaeum Style – Product Status 195

The Chaeum Style – Product Description 195

Ilooda Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 196

reepot Nd; YAG Laser System – Product Status 196

reepot Nd; YAG Laser System – Product Description 196

ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 197

Freedom Implant – Product Status 197

Freedom Implant – Product Description 197

InMode Ltd Pipeline Products & Ongoing Clinical Trials Overview 198

Next Generation Evoke – Product Status 198

Next Generation Evoke – Product Description 198

Trim II – Product Status 199

Trim II – Product Description 199

InMode Ltd – Ongoing Clinical Trials Overview 200

Trim II – Safety and Efficacy of Trim II for Non-invasive Lipolysis and Circumference Reduction of Abdomen 201

Innova Medical Design Pipeline Products & Ongoing Clinical Trials Overview 202

Aesthetic Injection – Product Status 202

Aesthetic Injection – Product Description 202

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 203

Breast Implant Shell – Product Status 203

Breast Implant Shell – Product Description 203

Wrinkle Filler – Product Status 204

Wrinkle Filler – Product Description 204

inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 205

Fractomer – Product Status 205

Fractomer – Product Description 205

Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 206

RF Laser Device – Product Status 206

RF Laser Device – Product Description 206

Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 207

IVL-MD-B001 – Product Status 207

IVL-MD-B001 – Product Description 207

IVL-MD-F001 – Product Status 208

IVL-MD-F001 – Product Description 208

IVL-MD-F002 – Product Status 208

IVL-MD-F002 – Product Description 209

Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

HA Filler – Product Status 210

HA Filler – Product Description 210

HA Thread Filler – Product Status 211

HA Thread Filler – Product Description 211

Wool Filler – Product Status 212

Wool Filler – Product Description 212

Jointechlabs Inc Pipeline Products & Ongoing Clinical Trials Overview 213

Mini-Stem System – Product Status 213

Mini-Stem System – Product Description 213

Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

Tenergel – Product Status 214

Tenergel – Product Description 214

Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 215

Autologous Globin Dermal Filler – Product Status 215

Autologous Globin Dermal Filler – Product Description 215

Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 216

IPN-21-SENSE Dermal Filler – Product Status 216

IPN-21-SENSE Dermal Filler – Product Description 216

Laboratoires Vivacy SAS – Ongoing Clinical Trials Overview 217

IPN-21-SENSE Dermal Filler – A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face 218

Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 219

MATTISSE – Product Status 219

MATTISSE – Product Description 219

Lattice Medical – Ongoing Clinical Trials Overview 220

MATTISSE – First-in-human, Study of MATTISSE Tissue Engineering Chamber in Adult Female Patients Undergoing Immediate Breast Reconstruction After Mastectomy for Cancer 221

Lavish Pipeline Products & Ongoing Clinical Trials Overview 222

Straberi Epistamp Microneedling Device – Product Status 222

Straberi Epistamp Microneedling Device – Product Description 222

Lavish – Ongoing Clinical Trials Overview 223

Straberi Epistamp Microneedling Device – Clinical Trial Study for the Use of Straberi Epistamp Needling Device to Treat Postinflammatory Hyperpigmentation (PIH) 224

Straberi Epistamp Microneedling Device – Clinical Trial Study for the Use of Straberi Microneedling Device to Treat Atrophic Acne Scarring 224

Straberi Epistamp Microneedling Device – Face Study of the Effects of Needling Using the Straberi Epistamp for the Improvement of Fine Lines and Skin Laxity. 224

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

Dermal Filler (LR19059) – Product Status 225

Dermal Filler (LR19059) – Product Description 225

Dermal Filler (LR19093) – Product Status 226

Dermal Filler (LR19093) – Product Description 226

Hyaluronic Acid Filler (LR19094) – Product Status 226

Hyaluronic Acid Filler (LR19094) – Product Description 226

Hyaluronic Acid Filler (LR20024) – Product Status 227

Hyaluronic Acid Filler (LR20024) – Product Description 227

Next Generation Hyaluronic Acid Filler (LR20008) – Product Status 227

Next Generation Hyaluronic Acid Filler (LR20008) – Product Description 227

YVOIRE Y-Solution 360 – Product Status 228

YVOIRE Y-Solution 360 – Product Description 228

YVOIRE Y-Solution 540 – Product Status 228

YVOIRE Y-Solution 540 – Product Description 229

YVOIRE Y-Solution 720 – Product Status 229

YVOIRE Y-Solution 720 – Product Description 229

LG Chem Ltd – Ongoing Clinical Trials Overview 230

YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 231

YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 232

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 233

LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 234

Artia – Breast Reconstruction – Product Status 234

Artia – Breast Reconstruction – Product Description 234

Strattice Reconstructive Tissue Matrix – Face Lift – Product Status 235

Strattice Reconstructive Tissue Matrix – Face Lift – Product Description 235

LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 236

Injectable Nanofiber-Hydrogel Matrix – Product Status 236

Injectable Nanofiber-Hydrogel Matrix – Product Description 236

Lumina – Product Status 237

Lumina – Product Description 237

LifeSprout Inc – Ongoing Clinical Trials Overview 238

Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 239

LigthSense Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 240

S2 Picosecond Laser – Product Status 240

S2 Picosecond Laser – Product Description 240

LigthSense Israel Ltd – Ongoing Clinical Trials Overview 241

S2 Picosecond Laser – A Single-center, Open-label, Uncontrolled Pilot Study to Evaluate the Safety and Efficacy of S2 – Multi-wavelength Laser for Tattoo Removal 242

ManaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 243

FB Professional LED Red Light Therapy System – Product Status 243

FB Professional LED Red Light Therapy System – Product Description 243

Medality Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 244

HydraSolve T2D – Product Status 244

HydraSolve T2D – Product Description 244

Medality Medical LLC – Ongoing Clinical Trials Overview 245

HydraSolve T2D – Evaluation of the Removal of Excess Intra-abdominal Fat in Subjects with Type 2 Diabetes and Obesity, Using the HydraSolve T2D System, on Glucose Control, Insulin Resistance and Body Weight 246

Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 247

Green Laser – 532 nm – Product Status 247

Green Laser – 532 nm – Product Description 247

Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 248

MT943 – Product Status 248

MT943 – Product Description 248

MT945 – Product Status 249

MT945 – Product Description 249

MTP50 – Product Status 249

MTP50 – Product Description 249

MTP51 – Product Status 250

MTP51 – Product Description 250

Neuramis Deep Lidocaine – Product Status 250

Neuramis Deep Lidocaine – Product Description 251

Neuramis Volume Lidocaine – Product Status 251

Neuramis Volume Lidocaine – Product Description 251

Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 252

Mentor – Becker Round Adjustable Gel Implant – Product Status 252

Mentor – Becker Round Adjustable Gel Implant – Product Description 252

Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 253

VP1 Lido US – Product Status 253

VP1 Lido US – Product Description 253

Merz North America Inc – Ongoing Clinical Trials Overview 254

VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 255

Merz Pharma GmbH & Co KgaA Pipeline Products & Ongoing Clinical Trials Overview 256

Figures

Aesthetic Devices – Pipeline Products by Stage of Development 32

Aesthetic Devices – Pipeline Products by Segment 33

Aesthetic Devices – Pipeline Products by Territory 35

Aesthetic Devices – Pipeline Products by Regulatory Path 37

Aesthetic Devices – Pipeline Products by Estimated Approval Date 39

Aesthetic Devices – Ongoing Clinical Trials 40

Frequently asked questions

Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.